iShares Health Innovation Active ETF BMED
37.17 USD +0.89 (+2.45%)
Nov 4, 2026, 3:08 PM EST
36.69 Day range 37.15
27.25 52-week range 37.15
- YTD
- +22.59%
- 1 year
- +31.90%
- Market cap
- 14.51M
- EPS (ttm)
- 1.02
- P/E ratio
- 36.31
- YTD return
- +22.59%
- 1-year return
- +31.90%
- Volume
- 37.89K
- Avg volume
- 2.11K
- Open
- 36.89
- Previous close
- 36.28
- Day's range
- 36.69 – 37.15
- 52-week range
- 27.25 – 37.15
2Y +11.25 (+43.50%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 25.76
- 200-day average
- 25.58
About iShares Health Innovation Active ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries. While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
News
3 Longevity ETFs to Buy and Hold (and Hold) 
World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements 
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 
Can Health Care Stocks Outperform Again In 2023? 
BlackRock Releases Megatrends Report 
Medical Device ETF Debuts
Your note
Sign in to keep a note on BMED — it syncs with the Stock Master app.